Kenneth Allen Myszkowski - Chief Financial Officer, Arrowhead Pharmaceuticals, Inc

As of August 24, 2016


Kenneth Allen Myszkowski Net Worth

  • Net worth is estimated to be at least $42.88M
  • Owns at least 115,689 units of Arrowhead Pharmaceuticals, Inc stock
  • Sold an estimated value of $1.02M in the last 6 years at Arrowhead Pharmaceuticals, Inc

Kenneth Allen Myszkowski Compensation at Arrowhead Pharmaceuticals, Inc in 2020

  • Earned a $463,750 salary
  • Rewarded $5,391,550 in stock value and options
  • Received a total compensation of $6,081,852

Kenneth Allen Myszkowski Trading

  • Largest purchase of shares was 40,000 units , worth over $252.85K on August 19, 2014
  • Largest sale of shares was 40,000 units , worth over $560.86K on August 19, 2014
  • In total has made about 12 transactions over 6 years
  • Usually trades in August, with the busiest year in 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Kenneth Allen Myszkowski Mailing Address

  • Mailing address is Arrowhead Research Corporation 201 South Lake Avenue, Suite 703 Pasadena CA 91101 CA

Arrowhead Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Christopher Anzalone 2020 $785,625 - $12,686,000 - $820,000 $2,892 $14,294,517
Christopher Anzalone 2019 $674,375 - - - $1,540,000 $1,889 $2,216,264
Christopher Anzalone 2018 $643,012 - - - $975,000 $1,889 $1,619,901
Kenneth Myszkowski 2020 $463,750 - $5,391,550 - $213,750 $12,802 $6,081,852
Kenneth Myszkowski 2019 $422,500 - $1,055,700 - $251,550 $11,799 $1,741,549
Kenneth Myszkowski 2018 $384,841 - $276,000 - $180,000 $12,177 $853,018
Javier San Martin 2020 $380,769 $100,000 $7,225,500 - $180,000 $12,802 $7,899,071
Javier San Martin 2019 - - - - - - -
Javier San Martin 2018 - - - - - - -
James Hassard 2020 $302,404 - $7,430,000 - $170,000 $15,892 $7,918,296
James Hassard 2019 - - - - - - -
James Hassard 2018 - - - - - - -
Curt Bradshaw 2020 $338,462 - $6,021,250 - - $13,494 $6,373,206
Curt Bradshaw 2019 - - - - - - -
Curt Bradshaw 2018 - - - - - - -
Bruce D. Given 2020 $409,615 - $15,857,500 - - $76,693 $16,343,808
Bruce D. Given 2019 $488,750 - $2,608,200 - $850,000 $11,799 $3,958,759
Bruce D. Given 2018 $450,362 - $644,000 - $445,900 $11,799 $1,552,061
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/879407/000119312521019640/d76219ddef14a.htm

Arrowhead Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 5,000 units sold on September 14, 2021 by Adeoye Olukotun worth over $318.8K
  • In the last 17 years, insiders at Arrowhead Pharmaceuticals, Inc sold an estimated value of $132.52M and bought an estimated value of $9.12M
  • The most active traders are Christopher Anzalone, Chief Executive Officer,  Kenneth Myszkowski, Chief Financial Officer,  and Charles McKenney, Director
  • Insider trading is most common in January, with the busiest year in 2019

ARROWHEAD PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1